Found 26 matching trials
A Study of the Safety and Immunogenicity of Repeated rhC1INH Administration
PHASE2Hereditary angioedema ("HAE") is a disease characterized by recurrent tissu...
Location
For information on sites, please contact Pharming Technologies
Efficacy, Safety and Immunogenicity Study of Recombinant Human C1 Inhibitor for the Treatment of Acute HAE Attacks
PHASE3This study is being conducted to confirm the efficacy, safety, and immunoge...
Location
Allergy, Asthma & Immunology, Assoc, Ltd.
Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of Recombinant Human C1 Esterase Inhibitor in Healthy Adult Subjects
PHASE1This trial is looking to gain information about the safety and tolerability...
Location
Clinical Pharmacology of Miami
RUCONEST® as a Therapeutic Strategy to Reduce the Incidence of Delayed Graft Function
PHASE1An unmet medical need exists for therapeutic regimens in transplantation th...
Location
University of Wisconsin
Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19
PHASE2The aim of this study is to analyze if administration of conestat alfa for ...
Location
Práxis Pesquisa Medica
A Study to Evaluate the Benefit of RUCONEST® in Subjects Who Experience ADRs Related to IVIG Infusions
PHASE4Patients receiving intravenous immunoglobulin (IVIG) therapy for primary im...
Location
IMMUNOe Research Centers
Combined Drug Approach to Prevent Ischemia-reperfusion Injury During Transplantation of Livers (CAPITL)
PHASE2The purpose of this study is to establish the effectiveness of the combined...
Location
University Hospitals Leuven
Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema
PHASE2Hereditary angioedema ("HAE") is a genetic disorder characterized by sudden...
Location
For information on sites please contact Pharming Medical Affairs Department
Patient Registry to Evaluate the Real-world Safety of Ruconest®
N/AThis is a prospective, real-world, observational patient registry for patie...
Location
The US Hereditary Angioedema Association
Treatment of Hereditary Angioedema Prodrome with Recombinant C1-esterase Inhibitor (Ruconest)
PHASE4To assess the efficacy of recombinant human C1-esterase inhibitor in the ma...
Location
Clinical Research Center of Alabama